Ingrid Oakley-Girvan

Publications

• Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? Weaver KE, Foraker RE, Alfano CM, Rowland JH, Arora NK, Bellizzi KM, Hamilton AS, Oakley-Girvan I, Keel G, Aziz NM. J Cancer Surviv. 2013; 7 (2): 253-61
• Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Mæhle L, Møller P, Eeles R, Easton D, Guy M, Edwards S, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Stanford JL, Karyadi DM, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Lange EM, Cooney KA, Tammela TL, Schleutker J, Maier C, Bochum S, Hoegel J, Grönberg H, Wiklund F, Emanuelsson M, Cancel-Tassin G, Valeri A, Cussenot O, Isaacs WB. BMC Med Genet. 2012: 13 46
• Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Grönberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL, FitzGerald LM, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Whittemore AS, Oakley-Girvan I, Hsieh CL, Powell I, Bailey-Wilson JE, Cropp CD, Simpson C, Carpten JD, Seminara D, Zheng SL, Xu J, Giles GG, Severi G, Hopper JL, English DR, Foulkes WD, Maehle L, Moller P, Badzioch MD, Edwards S, Guy M, Eeles R, Easton D, Isaacs WB. Prostate. 2012; 72 (4): 410-26
• Complementary and alternative medicine use among newly diagnosed prostate cancer patients. McDermott CL, Blough DK, Fedorenko CR, Arora NK, Zeliadt SB, Fairweather ME, Oakley-Girvan I, Van Den Eeden SK, Ramsey SD. Support Care Cancer. 2012; 20 (1): 65-73
• Double Jeopardy? Age, Race, and HRQOL in Older Adults with Cancer. Bellizzi KM, Aziz NM, Rowland JH, Weaver K, Arora NK, Hamilton AS, Oakley-Girvan I, Keel G. J Cancer Epidemiol. 2012: 2012 478642
• Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, Hamilton AS, Oakley-Girvan I, Beckjord EB, Aziz NM. Patient Educ Couns. 2012; 89 (2): 345-52
• Quality of life of younger breast cancer survivors: persistence of problems and sense of well-being. Bloom JR, Stewart SL, Oakley-Girvan I, Banks PJ, Shema S. Psychooncology. 2012; 21 (6): 655-65
• Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Grönberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J. Hum Genet. 2012; 131 (7): 1095-103
• Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. J Clin Oncol. 2011; 29 (10): 1280-9
• Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Farnham JM, Cannon-Albright LA, Camp NJ. Prostate. 2010; 70 (7): 735-44
• Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. Zeliadt SB, Ramsey SD, Van Den Eeden SK, Hamilton AS, Oakley-Girvan I, Penson DF, Fairweather ME, Arora NK, Potosky AL. Am J Clin Oncol. 2010; 33 (4): 381-6
• Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL. J Urol. 2010; 184 (1): 120-5
• Access to information sources and treatment considerations among men with local stage prostate cancer. Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF. Urology. 2009; 74 (3): 509-15
• Follow-up care delivery among colorectal cancer survivors most often seen by primary and subspecialty care physicians. Haggstrom DA, Arora NK, Helft P, Clayman ML, Oakley-Girvan I. J Gen Intern Med. 2009: 24 Suppl 2 S472-9
• Physicians' decision-making style and psychosocial outcomes among cancer survivors. Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Potosky AL. Patient Educ Couns. 2009; 77 (3): 404-12
• Association of Preexisting Symptoms with Treatment Decisions among Newly Diagnosed Prostate Cancer Patients. Zeliadt SB, Ramsey SD, Potosky AL, Arora NK, Blough DK, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Penson DF. Patient. 2008; 1 (3): 189
• Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. J Cancer Surviv. 2008; 2 (3): 179-89
• Prostate cancer risk in relation to insulin-like growth factor (IGF)-I and IGF-binding protein-3: a prospective multiethnic study. Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Cancer Epidemiol Biomarkers Prev. 2008; 17 (1): 252-4
• Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Isaacs WB. Hum Mol Genet. 2007; 16 (11): 1271-8
• Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Ramus SJ, Harrington PA, Pye C, DiCioccio RA, Cox MJ, Garlinghouse-Jones K, Oakley-Girvan I, Jacobs IJ, Hardy RM, Whittemore AS, Ponder BA, Piver MS, Pharoah PD, Gayther SA. Hum Mutat. 2007; 28 (12): 1207-15
• Multiple regions within 8q24 independently affect risk for prostate cancer. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, Neubauer J, Tandon A, Schirmer C, McDonald GJ, Greenway SC, Stram DO, Le Marchand L, Kolonel LN, Frasco M, Wong D, Pooler LC, Ardlie K, Oakley-Girvan I, Whittemore AS, Cooney KA, John EM, Ingles SA, Altshuler D, Henderson BE, Reich D. Nat Genet. 2007; 39 (5): 638-44
• Prediagnostic C-peptide and risk of prostate cancer. Borugian MJ, Spinelli JJ, Sun Z, Kolonel LN, Oakley-Girvan I, Pollak MD, Whittemore AS, Wu AH, Gallagher RP. Cancer Epidemiol Biomarkers Prev. 2007; 16 (10): 2164-5
• Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D. Proc Natl Acad Sci U S A. 2006; 103 (38): 14068-73
• Family history, perceived risk, and prostate cancer screening among African American men. Bloom JR, Stewart SL, Oakley Girvan I, Oakley-Girvans I, Banks PJ, Chang S. Cancer Epidemiol Biomarkers Prev. 2006; 15 (11): 2167-73
• Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, Bishop DT, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Guy M, Hsieh CL, Halpern J, Balise RR, Oakley-Girvan I, Whittemore AS, Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Friedrichsen DM, Deutsch K, Kolb S, Janer M, Hood L, Ostrander EA, Stanford JL, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Lange EM, Ho LA, Beebe-Dimmer JL, Wood DP, Cooney KA, Seminara D, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TL, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Grönberg H, Camp NJ, Farnham J, Cannon-Albright LA, Catalona WJ, Suarez BK, Roehl KA. Hum Genet. 2006; 120 (4): 471-85
• A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLj, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D. Am J Hum Genet. 2005; 77 (2): 219-29
• Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Int J Gynecol Pathol. 2004; 23 (1): 29-34
• Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, Piver MS. Br J Cancer. 2004; 91 (11): 1911-5
• Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Oakley-Girvan I, Feldman D, Eccleshall TR, Gallagher RP, Wu AH, Kolonel LN, Halpern J, Balise RR, West DW, Paffenbarger RS, Whittemore AS. Cancer Epidemiol Biomarkers Prev. 2004; 13 (8): 1325-30
• Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients. Oakley-Girvan I, Kolonel LN, Gallagher RP, Wu AH, Felberg A, Whittemore AS. Am J Public Health. 2003; 93 (10): 1753-9
• Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, Felberg A, Gallagher RP, Whittemore AS. Cancer Causes Control. 2002; 13 (5): 471-82
• A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, Kolonel LN, O'Brien LE, Lin IG, Van Den Berg DJ, Teh CZ, West DW, Whittemore AS. Am J Hum Genet. 2001; 69 (1): 148-58
• Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Dicioccio RA, Tsukada Y, Ponder BA, Piver MS. Hum Pathol. 2000; 31 (11): 1420-4
• Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. Werness BA, Parvatiyar P, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Wiest J, Tsukada Y, Ponder BA, Piver MS. J Natl Cancer Inst. 2000; 92 (13): 1088-91
• Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation. Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS. Int J Gynecol Pathol. 2000; 19 (4): 390-4
• Survival in epithelial ovarian cancer patients with prior breast cancer. McGuire V, Whittemore AS, Norris R, Oakley-Girvan I. Am J Epidemiol. 2000; 152 (6): 528-32
• Dietary fat, calories, and prostate cancer risk. Bosland MC, Oakley-Girvan I, Whittemore AS. J Natl Cancer Inst. 1999; 91 (6): 489-91
• No evidence of linkage for chromosome 1q42.2-43 in prostate cancer. Whittemore AS, Lin IG, Oakley-Girvan I, Gallagher RP, Halpern J, Kolonel LN, Wu AH, Hsieh CL. Am J Hum Genet. 1999; 65 (1): 254-6
• Re: prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. Hsieh CL, Oakley-Girvan I, Gallagher RP, Wu AH, Kolonel LN, Teh CZ, Halpern J, West DW, Paffenbarger RS, Whittemore AS. J Natl Cancer Inst. 1997; 89 (24): 1893-4
• Risks of cancer among members of families in the Gilda Radner Familial Ovarian Cancer Registry. Jishi MF, Itnyre JH, Oakley-Girvan IA, Piver MS, Whittemore AS. Cancer. 1995; 76 (8): 1416-21
• Quantitative anatomical study of taste buds n fungiform papillae of young and old Fischer rats Mistretta CM, Oakley IA. J Gerontol. 1986; 41 (3): 315-318